03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Clinician · Diabetes
Anna Clarke
clinical research nurse
press citations on 1 topic since 11 Nov 2026 · last quoted 11 Nov 2026
02 Quoted on · 1 of 29 topics
Anna Clarke: key facts
- Kind of voice
- Clinician
- Role
- clinical research nurse
- Quoted on
- Diabetes
- Tracked press citations
- 3
- Most recently quoted
- 11 Nov 2026
04 The signal · where Anna Clarke sits on diabetes
Ranked 48= of 100 voices quoted in the press on diabetes, level with 35 others on 3 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Douglas TwenefourClinicianHead of Clinical, Diabetes UK36 - 2
Dr Elizabeth RobertsonSector leaderDirector of Research and Clinical, Diabetes UK20 - 3=
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)15 - 48=Donald GrantClinicianGP and Senior Clinical Advisor at The Independent Pharmacy3
- 48=Thomas SeckAcademicM.D., senior vice president of product development, Lilly Cardiometabolic3
- 48=Anna ClarkeClinicianclinical research nurse3
- 48=Mark VerdantSector leaderclinical trials support officer at Somerset NHS Foundation Trust3
- 48=Prof. Roman HovorkaAcademicFounder of CamDiab3
Showing the leaders and the ranks around 48=, of 100 voices · See every voice on the topic →
05 On the record · press
What Anna Clarke has said
- burnhamandhighbridgeweeklynews.co.uk1
- chardandilminsternews.co.uk1
- somersetcountygazette.co.uk1
Where Anna Clarke has been quoted
- 01Musgrove Park seeks volunteers for trial of new type 2 diabetes treatmentsomersetcountygazette.co.uk · 11 Nov 2026
- 02Musgrove Park supports research into experimental diabetes treatmentchardandilminsternews.co.uk · 11 Nov 2026
- 03Musgrove Park joins international research into type 2 diabetes treatmentburnhamandhighbridgeweeklynews.co.uk · 11 Nov 2026
Verbatim
“Taking part is a significant commitment, with the study lasting around a year and a half, but people are supported throughout by our research team and will have regular assessments and monitoring.”
“Enith 2 is looking at a new potential treatment for people who have type 2 diabetes and are also living with overweight or obesity.”
“Enith 2 is looking at a new potential treatment for people who have type 2 diabetes and are also living with overweight or obesity.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.